137 related articles for article (PubMed ID: 20564918)
21. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
22. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
23. Does ambroxol confer a protective effect on the lungs in patients undergoing cardiac surgery or having lung resection?
Wang S; Huang D; Ma Q; Chen X
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):830-4. PubMed ID: 24623642
[TBL] [Abstract][Full Text] [Related]
24. [Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease].
Titova ON; Ignat'ev VA; Didur MD; Kameneva MIu; Sukhovskaia OA
Ter Arkh; 2008; 80(3):28-33. PubMed ID: 18441680
[TBL] [Abstract][Full Text] [Related]
25. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
26. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease].
Lin SD; Dai AG; Xu P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):97-101. PubMed ID: 15854390
[TBL] [Abstract][Full Text] [Related]
27. [A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion].
Li W; Mao B; Wang G; Wang L; Chang J; Zhang Y; Wan MH; Guo J
Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):799-805. PubMed ID: 18664347
[TBL] [Abstract][Full Text] [Related]
28. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
29. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
30. [Effect of intravenous ambroxol hydrochloride on lung function and exercise capacity in patients with severe chronic obstructive pulmonary disease].
Puścińska E; Radwan L; Zieliński J
Pneumonol Alergol Pol; 1994; 62(5-6):246-9. PubMed ID: 7920274
[TBL] [Abstract][Full Text] [Related]
31. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
[TBL] [Abstract][Full Text] [Related]
32. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
33. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
34. Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease.
Kanat F; Vatansev H; Teke T
Neth J Med; 2007 Sep; 65(8):296-300. PubMed ID: 17890789
[TBL] [Abstract][Full Text] [Related]
35. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients.
Sasaki T; Nakayama K; Yasuda H; Yoshida M; Asamura T; Ohrui T; Arai H; Araya J; Kuwano K; Yamaya M
J Am Geriatr Soc; 2009 Aug; 57(8):1453-7. PubMed ID: 19515110
[TBL] [Abstract][Full Text] [Related]
36. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
Michnar M; Milanowski J
Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of ceruloplasmin in patients with asthma].
Farkhutdinov UR; Farkhutdinov ShU
Ter Arkh; 2012; 84(12):45-8. PubMed ID: 23479988
[TBL] [Abstract][Full Text] [Related]
39. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases.
Teramoto S; Suzuki M; Ohga E; Ishii T; Matsui H; Matsuse T; Ouchi Y
Pharmacology; 1999 Sep; 59(3):135-41. PubMed ID: 10450068
[TBL] [Abstract][Full Text] [Related]
40. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
